Ga68-NODAGA-MJ9

N/A

Report date: 2025/11/20 16:02:35
NME

Base Information

Drug NameGa68-NODAGA-MJ9
Drug Alias NameGa-68-NODAGA-MJ9
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4
Mechanisms of ActionGastrin releasing peptide receptor binders
TargetsGastrin releasing peptide receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesLausanne University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A